Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | RXRB | P28702 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9799609 | 1.00 | ELANE (0.46) | ELANEALDH1A1MAPTPTK2BMEN1 | |
| Hydrochloric Acid SCHEMBL27455927 | 0.98 | ELANE (0.45) | ELANEALDH1A1MAPTPTK2BMEN1 | |
| SCHEMBL8435546 | 0.86 | ALOX15 (0.55) | ELANEALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL1261928 | 0.85 | HTR1D (0.46) | ELANEALDH1A1MEN1KMT2AALOX15 | |
| SCHEMBL6917578 | 0.85 | ALDH1A1 (0.54) | ALDH1A1MAPTPTK2BMEN1KMT2A | |
| SCHEMBL8496813 | 0.84 | PTK2B (0.47) | ALDH1A1MAPTPTK2BMEN1KMT2A | |
| SCHEMBL15547750 | 0.84 | KMT2A (0.43) | ELANEALDH1A1MEN1KMT2AALOX15 | |
| SCHEMBL27952004 | 0.84 | MRGPRX4 (0.47) | ELANEALDH1A1MAPTKMT2APOLB | |
| SCHEMBL27964082 | 0.84 | ACHE (0.41) | ELANEALDH1A1MEN1KMT2AALOX15 | |
| SCHEMBL28189795 | 0.82 | MEN1 (0.50) | MAPTPTK2BMEN1KMT2APKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116655652-A | New synthesis method of clopidogrel | 宿迁盛基医药科技有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-102250114-B | Preparation method of clopidogel and sulfate thereof | QINGDAO HUANGHAI PHARMACEUTICAL CO LTD | 2014-02-26 | — | — | CN | claimed |
| CN-101519401-B | Intermediate (S)-2-(2-thiophene ethylamine)(2-chlorphenyl)methyl acetate of clopidogrel and method for preparing salts thereof | SHANGHAI ECUST BIOMEDICINE CO LTD | 2012-12-05 | — | — | CN | claimed |
| CN-102438450-A | fruit thinning agent | TAMINCO NV | 2012-05-02 | — | — | CN | claimed |
| CN-102250114-A | Preparation method of clopidogel and sulfate thereof | QINGDAO HUANGHAI PHARMACEUTICAL CO LTD | 2011-11-23 | — | — | CN | claimed |
| CN-101909451-A | Fungicidal mixtures II | BASF SE | 2010-12-08 | — | — | CN | claimed |
| CN-101519401-A | Intermediate (S)-2-(2-thiophene ethylamine)(2-chlorphenyl)methyl acetate of clopidogrel and method for preparing salts thereof | SHANGHAI ECUST BIOMEDICINE CO | 2009-09-02 | — | — | CN | claimed |
| CN-110300744-B | Compounds for optically active devices | 爱尔兰眼力健公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-116655652-A | New synthesis method of clopidogrel | 宿迁盛基医药科技有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-116655652-A | New synthesis method of clopidogrel | 宿迁盛基医药科技有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-106061267-B | Application of chemical agent in stone fruit flower thinning | 精细农用化学品有限公司 | 2022-02-01 | — | — | CN | disclosed |
| US-20210387996-A1 | TRICYCLIC COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE | HOFFMANN-LA ROCHE INC. (US) | 2021-12-16 | — | — | US | disclosed |
| CN-111606923-B | Synthesis method of racemic clopidogrel | 武汉理工大学 | 2021-08-24 | — | — | CN | disclosed |
| US-4347177-A | Compounds and methods of making them | BURROUGHS WELLCOME CO. (US) | 1982-08-31 | — | — | US | disclosed |
| US-4347382-A | 3H Labeled compounds | BURROUGHS WELLCOME CO. (US) | 1982-08-31 | — | — | US | disclosed |
| US-4347176-A | Compounds and methods of making same | BURROUGHS WELLCOME CO. (US) | 1982-08-31 | — | — | US | disclosed |
| US-4347178-A | Compounds and methods of making | BURROUGHS WELLCOME CO. (US) | 1982-08-31 | — | — | US | disclosed |
| EP-0038071-A2 | New unlabelled and radioactive labelled derivatives of butylamino propiophenone, their preparation, immunogens obtained from the unlabelled derivatives and a process for immunogen preparation, antisera raised using the immunogens and a method for raising antisera, a radioimmunoassay method and a test kit for use in the assay method | THE WELLCOME FOUNDATION LIMITED (GB) | 1981-10-21 | — | — | EP | disclosed |
| US-4153707-A | Fungicidal isoxazolyl phenols and method of use | THE UPJOHN COMPANY (US) | 1979-05-08 | — | — | US | disclosed |
| US-4065574-A | New method for controlling fungi using 4-chromone, 4-chromanone, 4-chromone oxime and 4-chromanone oxime compounds | THE UPJOHN COMPANY (US) | 1977-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210387996-A1 | TRICYCLIC COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE | TOP2B, HAVCR2, SLC10A1 | ELANE 2526/4885ALDH1A1 1239/4885MAPT 3771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.